ReviewFrontiers in medicine2022
Cold Kit Labeling: The Future of
Review in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- ExpandingEJNMMI radiopharmacy and chemistry · 2026Article
- Establishment ofMolecular pharmaceutics · 2026Article
- Next-GenInternational journal of molecular sciences · 2026Article
- ScalableWorld journal of nuclear medicine · 2026Article
- Long-term performance evaluation of a novel 3.26 GBqEJNMMI radiopharmacy and chemistry · 2026Article
- Influences of Ring Sizes and Chiral Substituents on Macrocyclic Chelators for ImprovingJACS Au · 2026Article
- Optimized Automated Cassette-Based Synthesis of [Pharmaceuticals (Basel, Switzerland) · 2025Article
- Review
- GMP compliant simplified fast and high yielding automated synthesis of [EJNMMI radiopharmacy and chemistry · 2025Article
- Production and Supply of Raw Materials for Radiometals used in Radionuclide Imaging and Therapy in Korea.Nuclear medicine and molecular imaging · 2025Review
- Gallium-Labeled PET Radiopharmaceuticals in Cardiovascular Disease.Pharmaceuticals (Basel, Switzerland) · 2025Review
- The Environmental Impact of Medical Imaging Agents and the Roadmap to Sustainable Medical Imaging.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Review
- A comparison of routine [EJNMMI radiopharmacy and chemistry · 2024Article
- Towards Optimal AutomatedJournal of labelled compounds & radiopharmaceuticals · 2024Article
- Validation of a radiosynthesis method and a novel quality control system for [EJNMMI radiopharmacy and chemistry · 2024Article
- Automated Production of [Pharmaceutics · 2024Article
- Bisphosphonates as Radiopharmaceuticals: Spotlight on the Development and Clinical Use of DOTAZOL in Diagnostics and Palliative Radionuclide Therapy.International journal of molecular sciences · 2023Review
- Scandium Radioisotopes-Toward New Targets and Imaging Modalities.Molecules (Basel, Switzerland) · 2023Review
- Fully automated radiolabeling of [EJNMMI radiopharmacy and chemistry · 2023Article
- Radiometals in Imaging and Therapy: Highlighting Two Decades of Research.Pharmaceuticals (Basel, Switzerland) · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the last couple of decades, gallium-68 (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.